Hypoxia Pathways for Spinal Cord Injury
(HyPER-FLO Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new methods to help people with spinal cord injuries improve breathing and airway defense. It tests two breathing treatments, Acute Intermittent Hypercapnic-Hypoxia (AIHH) and Augmented Acute Intermittent Hypoxia (aAIH), by exposing participants to low oxygen levels to determine which better enhances breathing ability. The trial also examines how genetics might influence a person's response to these treatments. Suitable candidates have had a spinal cord injury from 1 to 6 months ago and are medically stable. Participants will try each treatment on separate days to assess their response. As an unphased trial, this study offers participants the chance to contribute to pioneering research that could lead to new treatments for spinal cord injuries.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Studies have shown that treatments like those in this trial, which involve brief exposure to low oxygen levels, are generally well-tolerated. Research indicates these treatments can safely enhance nerve pathways in people with spinal cord injuries. Controlled exposure to low oxygen levels encourages recovery without significant risks.
This trial tests two specific treatments: acute intermittent hypercapnic-hypoxia (AIHH) and augmented acute intermittent hypoxia (aAIH). Promising data supports both. AIHH has increased blood pressure and nerve activity, potentially aiding recovery, and studies suggest it effectively and safely improves breathing. Similarly, aAIH shows potential for enhancing breathing and movement, with evidence indicating safety when used alone or with other therapies.
While no major safety concerns have been reported, about 40% of people may not respond strongly to these treatments. However, studies have not highlighted any significant adverse effects, suggesting these treatments are generally safe for participants.12345Why are researchers excited about this trial?
Researchers are excited about exploring Hypoxia Pathways for Spinal Cord Injury because these techniques could offer a fresh approach to treatment. Unlike standard treatments that often focus on surgery or medication to manage symptoms, Acute Intermittent Hypercapnic-Hypoxia (AIHH) and Augmented Acute Intermittent Hypoxia (aAIH) involve controlled exposure to low oxygen levels and carbon dioxide variations to potentially trigger pathways that boost recovery. This non-invasive method could promote neural plasticity, which is the ability of the brain and spinal cord to adapt and repair itself. If successful, these methods might provide quicker or more effective recovery options for spinal cord injury patients by tapping into the body's natural repair mechanisms.
What evidence suggests that this trial's treatments could be effective for spinal cord injury?
Research has shown that a treatment called acute intermittent hypoxia (AIH) can improve movement in people with spinal cord injuries by making the spinal cord more adaptable. Studies have found that AIH enhances breathing and limb movement in these individuals. However, about 40% of people might not experience significant improvement with AIH, highlighting the need to optimize its use.
This trial will test different versions of AIH, including augmented acute intermittent hypoxia (aAIH) and acute intermittent hypercapnic-hypoxia (AIHH). Early research suggests that aAIH might improve breathing control even more effectively than regular AIH. In one study, a single AIH session increased grip and pinch strength, with the best results observed about three hours after treatment. Both AIH and aAIH aim to improve breathing by encouraging changes in the spinal cord, but their effectiveness can vary among individuals. Participants in this trial will receive interventions in different sequences, including Sham, AIHH, and aAIH, to evaluate their effectiveness.23678Who Is on the Research Team?
Emily J Fox, PT, DPT, MHS, PhD
Principal Investigator
University of Florida & Brooks Rehabilitation
Are You a Good Fit for This Trial?
This trial is for adults aged 18-70 with sub-acute incomplete or complete spinal cord injury (SCI) at or below C1-T6, occurring 1 to 6 months prior. Participants must be medically stable with physician clearance and have SCI from a non-progressive cause. Excluded are those with other neurological conditions, severe illness/infection, uncontrolled issues like hypertension, neuropathic pain, pregnancy, or current acute care hospitalization.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Testing
Baseline testing will be performed before each intervention day
Intervention
Participants will receive interventions in the order of Sham, AIHH, and aAIH on separate days
Post-Intervention Testing
Post-testing will occur after each intervention to measure primary and secondary outcomes
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Acute Intermittent Hypercapnic-Hypoxia (AIHH)
- Augmented Acute Intermittent Hypoxia (aAIH)
- Sham AIH
Trial Overview
The study tests two hypoxia protocols on individuals with recent SCI: Augmented Acute Intermittent Hypoxia (aAIH), which may enhance respiratory function via adenosine mechanisms; and Acute Intermittent Hypercapnic-Hypoxia (AIHH), targeting serotonin pathways. A sham procedure serves as control. The goal is to determine the best approach for promoting respiratory motor plasticity and identify genetic markers predicting treatment response.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Placebo Group
Participants will complete a baseline testing session, 6 sessions of augmented acute intermittent hypoxia (aAIH) intervention (3, 5-minute episodes of 9-13% O2, 3-minute intervals), and post-test assessments 1-day and 1-week after the last intervention.
Participants will complete a baseline testing session, 6 sessions of acute intermittent hypercapnic hypoxia (AIHH) intervention (15, 1-minute episodes of 9-13% O2 + 4-5% CO2, 1.5-minute intervals), and post-test assessments 1-day and 1-week after the last intervention.
Participants will complete a baseline testing session, 6 sessions of sham intervention (5, 3-minute episodes of 21% O2, 2-minute intervals), and post-test assessments 1-day and 1-week after the last intervention.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor
Brooks Rehabilitation
Collaborator
Citations
Acute intermittent hypercapnic-hypoxia elicits central neural ...
The results indicate that moderate AIHH elicits a central neural mechanism of respiratory motor plasticity and increases resting respiratory drive in awake ...
Combined therapeutic acute intermittent hypercapnic ...
Unfortunately, tAIH effects on breathing function are less effective with chronic injury. On the other hand, tAIH restores non-respiratory (limb) ...
Hypoxia Pathways for Early Recovery After Spinal Cord Injury
The long-term objective of this line of work is to test the hypothesis that an acute intermittent hypoxia protocol (3, 5 min episodes, 9-13% ...
4.
jefferson.edu
jefferson.edu/academics/colleges-schools-institutes/rehabilitation-sciences/departments/outcomes-measurement/current-projects.htmlCurrent Projects
The outcomes from the current study establish the psychometric data to support the claim that assessing remotely is a valid and reliable way to measure physical ...
Acute Intermittent Hypoxia for Spinal Cord Injury
Research shows that Acute Intermittent Hypoxia (AIH) can improve motor function in individuals with chronic spinal cord injury by enhancing spinal plasticity, ...
Cardiorespiratory Responses to Acute Intermittent Hypoxia in ...
After spinal cord injury (SCI), cardiorespiratory control is impaired, threatening the regulation of arterial O2 and CO2 partial pressures and the transport of ...
Acute intermittent hypercapnic hypoxia augments left ...
Acute intermittent hypercapnic hypoxia (IHH) evokes persistent increases in vascular sympathetic activity and blood pressure.
Project Details
Identifying predictive biomarkers for acute intermittent hypoxia induced motor recovery in persons with incomplete spinal cord injury. 494, 1R03HD115657-01 ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.